Cargando…

Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease

OBJECTIVE(S): We recently developed a new uptake index method for (123)I-metaiodobenzylguanidine ((123)I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamiya, Yoshito, Ota, Satoru, Tanaka, Yuta, Yamashita, Kosuke, Takaki, Akihiro, Ito, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038978/
https://www.ncbi.nlm.nih.gov/pubmed/29998146
http://dx.doi.org/10.22038/aojnmb.2018.10595
_version_ 1783338601707208704
author Kamiya, Yoshito
Ota, Satoru
Tanaka, Yuta
Yamashita, Kosuke
Takaki, Akihiro
Ito, Shigeki
author_facet Kamiya, Yoshito
Ota, Satoru
Tanaka, Yuta
Yamashita, Kosuke
Takaki, Akihiro
Ito, Shigeki
author_sort Kamiya, Yoshito
collection PubMed
description OBJECTIVE(S): We recently developed a new uptake index method for (123)I-metaiodobenzylguanidine ((123)I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). However, the diagnostic accuracy of the uptake index was approximately equal to that of the heart-to-mediastinum ratio (H/M) for the discrimination of the LBD and non-LBD patients. A simple and pain-free uptake index method using (123)I-MIBG SPECT images by modifying the uptake index method may show better diagnostic accuracy than the planar uptake index method. We hypothesized that the development of a new uptake index method for the determination of (123)I-MIBG using single-photon emission computed tomography (SPECT) imaging would provide a reliable and reproducible diagnostic tool for clinical application. Regarding this, the purpose of this study was to develop a new uptake index method with a simple protocol to determine (123)I-MIBG uptake on SPECT. METHODS: The (123)I-MIBG input function was determined from the input counts of the pulmonary artery, assessed by analyzing the pulmonary artery time-activity curves. The (123)I-MIBG output function was obtained from (123)I-MIBG SPECT counts on the polar map. The uptake index was calculated through dividing the output function by the input function (SPECT uptake method). For the purpose of the study, 77 patients underwent (123)I-MIBG SPECT, with an average of 31.5 min after clinical assessment and injection of the tracer. The H/M values, as well as planar and SPECT uptake indices were calculated, and then correlated with clinical features. RESULTS: According to the results, values obtained for LBD were significantly lower than those for non-LBD in all analyses (P<0.01). The overlap of the H/M values between the LBD and non-LBD cases ranged from 2.06 to 2.50. Furthermore, the overlap in uptake index values between LBD and non-LBD cases in planar image analysis was 1.05-1.29. The SPECT uptake index method showed the least overlap of 1.23-1.25, with the highest value for LBD patients clearly distinguished from the lowest value for the non-LBD patients. CONCLUSION: The new (123)I-MIBG SPECT quantification method, developed by the input counts of the pulmonary artery, clearly distinguished LBD from non-LBD. Therefore, this method may be appropriate for routine clinical study.
format Online
Article
Text
id pubmed-6038978
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-60389782018-07-11 Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease Kamiya, Yoshito Ota, Satoru Tanaka, Yuta Yamashita, Kosuke Takaki, Akihiro Ito, Shigeki Asia Ocean J Nucl Med Biol Original Article OBJECTIVE(S): We recently developed a new uptake index method for (123)I-metaiodobenzylguanidine ((123)I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). However, the diagnostic accuracy of the uptake index was approximately equal to that of the heart-to-mediastinum ratio (H/M) for the discrimination of the LBD and non-LBD patients. A simple and pain-free uptake index method using (123)I-MIBG SPECT images by modifying the uptake index method may show better diagnostic accuracy than the planar uptake index method. We hypothesized that the development of a new uptake index method for the determination of (123)I-MIBG using single-photon emission computed tomography (SPECT) imaging would provide a reliable and reproducible diagnostic tool for clinical application. Regarding this, the purpose of this study was to develop a new uptake index method with a simple protocol to determine (123)I-MIBG uptake on SPECT. METHODS: The (123)I-MIBG input function was determined from the input counts of the pulmonary artery, assessed by analyzing the pulmonary artery time-activity curves. The (123)I-MIBG output function was obtained from (123)I-MIBG SPECT counts on the polar map. The uptake index was calculated through dividing the output function by the input function (SPECT uptake method). For the purpose of the study, 77 patients underwent (123)I-MIBG SPECT, with an average of 31.5 min after clinical assessment and injection of the tracer. The H/M values, as well as planar and SPECT uptake indices were calculated, and then correlated with clinical features. RESULTS: According to the results, values obtained for LBD were significantly lower than those for non-LBD in all analyses (P<0.01). The overlap of the H/M values between the LBD and non-LBD cases ranged from 2.06 to 2.50. Furthermore, the overlap in uptake index values between LBD and non-LBD cases in planar image analysis was 1.05-1.29. The SPECT uptake index method showed the least overlap of 1.23-1.25, with the highest value for LBD patients clearly distinguished from the lowest value for the non-LBD patients. CONCLUSION: The new (123)I-MIBG SPECT quantification method, developed by the input counts of the pulmonary artery, clearly distinguished LBD from non-LBD. Therefore, this method may be appropriate for routine clinical study. Mashhad University of Medical Sciences 2018 /pmc/articles/PMC6038978/ /pubmed/29998146 http://dx.doi.org/10.22038/aojnmb.2018.10595 Text en © 2018 mums.ac.ir All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kamiya, Yoshito
Ota, Satoru
Tanaka, Yuta
Yamashita, Kosuke
Takaki, Akihiro
Ito, Shigeki
Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
title Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
title_full Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
title_fullStr Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
title_full_unstemmed Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
title_short Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
title_sort development of an (123)i-metaiodobenzylguanidine myocardial three-dimensional quantification method for the diagnosis of lewy body disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038978/
https://www.ncbi.nlm.nih.gov/pubmed/29998146
http://dx.doi.org/10.22038/aojnmb.2018.10595
work_keys_str_mv AT kamiyayoshito developmentofan123imetaiodobenzylguanidinemyocardialthreedimensionalquantificationmethodforthediagnosisoflewybodydisease
AT otasatoru developmentofan123imetaiodobenzylguanidinemyocardialthreedimensionalquantificationmethodforthediagnosisoflewybodydisease
AT tanakayuta developmentofan123imetaiodobenzylguanidinemyocardialthreedimensionalquantificationmethodforthediagnosisoflewybodydisease
AT yamashitakosuke developmentofan123imetaiodobenzylguanidinemyocardialthreedimensionalquantificationmethodforthediagnosisoflewybodydisease
AT takakiakihiro developmentofan123imetaiodobenzylguanidinemyocardialthreedimensionalquantificationmethodforthediagnosisoflewybodydisease
AT itoshigeki developmentofan123imetaiodobenzylguanidinemyocardialthreedimensionalquantificationmethodforthediagnosisoflewybodydisease